Ipratropium bromide and Robitussin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ipratropium bromide (ipratropium bromide) and Robitussin (guaifenesin). Common drug interactions include death among females and rash among males.

The phase IV clinical study analyzes what interactions people have when they take Ipratropium bromide and Robitussin. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Ipratropium bromide?

Ipratropium bromide has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 17,965 Ipratropium bromide users. Check the latest studies of Ipratropium bromide.

What is Robitussin?

Robitussin has active ingredients of guaifenesin. eHealthMe is studying from 3,532 Robitussin users. Check the latest studies of Robitussin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

38 people who take Ipratropium bromide and Robitussin together, and have interactions are studied.

Ipratropium bromide and Robitussin drug interactions.

What are the common drug interactions of Ipratropium Bromide and Robitussin, by gender? *:

female:

Death
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
General physical health deterioration (weak health status)
Glossodynia (a burning or painful sensation in the tongue)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Hypocalcaemia (levels of calcium in blood serum are abnormally low)
Nephrogenic anaemia (anaemia due to kidney disease)
Neuropathy peripheral (surface nerve damage)
Neutropenia (an abnormally low number of neutrophils)
Oral pain

male:

Rash
Chronic kidney disease
Pulmonary embolism (blockage of the main artery of the lung)
Renal injury (kidney injury)
Restless legs syndrome (a powerful urge to move your legs)
Acute respiratory failure
Bradycardia (abnormally slow heart action)
Cough
Diarrhoea
Hallucination (an experience involving the perception of something not present)

What are the common drug interactions of Ipratropium Bromide and Robitussin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Chronic kidney disease
Renal failure (kidney dysfunction)
Renal injury (kidney injury)

40-49:

n/a

50-59:

Abdominal discomfort
Anxiety
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Back pain
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiac disorder
Chest discomfort
Confusional state
Cough
Dizziness

60+:

Pneumonia
Pyrexia (fever)
Chest discomfort
Dizziness
Mantle cell lymphoma (cancer of lymphocytes, a type of white blood cell)
Pulmonary embolism (blockage of the main artery of the lung)
Vomiting
Acute respiratory failure
Bradycardia (abnormally slow heart action)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

What are the existing conditions these people have? *

Bone Marrow Conditioning Regimen: 7 people, 18.42%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 7 people, 18.42%
Cough: 6 people, 15.79%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 13.16%
Multiple Myeloma (cancer of the plasma cells): 3 people, 7.89%
Respiratory Disorder (respiratory disease): 2 people, 5.26%
Headache (pain in head): 2 people, 5.26%
Burkitt Lymphoma (cancer of the lymphatic system): 2 people, 5.26%
Claustrophobia (fear of having no escape and being closed in small spaces): 2 people, 5.26%
Constipation: 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Ipratropium bromide and Robitussin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously